SCHEMBL23975682

SCHEMBL23975682

COCCOc1cccnn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
LDHA P00338 1/20 0.35
P2RX7 Q99572 1/20 0.34
FAAH O00519 3/20 0.33
MPO P05164 1/20 0.33
KDM1A O60341 1/20 0.33
LIPG Q9Y5X9 1/20 0.32
LMNA P02545 2/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
EGFR P00533 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415429 0.91 ALDH1A1 (0.34) LDHAP2RX7LMNAHDAC1HDAC6
SCHEMBL4276013 0.82 NPC1 (0.39) LMNAALDH1A1CYP3A4HSD17B10CTDSP1
SCHEMBL13139432 0.81 NCF1 (0.38) TSHRLMNAALDH1A1HSD17B10CTDSP1
SCHEMBL4272287 0.81 CYP2D6 (0.44) TSHRLMNAALDH1A1CYP1A2CYP3A4
SCHEMBL24702149 0.80 HPGD (0.34) TSHRLMNAHDAC1HDAC6HDAC5
SCHEMBL24702303 0.80 NPY5R (0.36) TSHRHDAC1HDAC6HDAC5
SCHEMBL34469739 0.79 HDAC1 (0.34) P2RX7HDAC1HDAC6HDAC5CTDSP1
SCHEMBL898231 0.79 SOAT1 (0.44) TSHRFAAHLMNACYP3A4
SCHEMBL3826445 0.78 TAAR1 (0.42) P2RX7HDAC1HDAC6HDAC5CYP1A2
SCHEMBL30226513 0.78 ALDH1A1 (0.42) P2RX7FAAHHDAC1HDAC6HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
WO-2021222363-A1 CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed